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NRAMP1
 gene polymorphisms such as 823 C/T (exon 
8), deletion of TGTG in the 3'-UTR (3′ untranslated 
region) and D543N G/A (exon 15) were studied to 
find out whether the gene polymorphic variants are 
associated with the susceptibility or resistance to 
tuberculosis (TB). The study was carried out in pul-
monary (n = 100) and spinal TB patients (n = 57) and 
control subjects (n = 112). No difference was ob-
served in the variant genotype frequencies of 
NRAMP1 – 823 C/T, TGTG+/del and D543N G/A 
polymorphisms. However, a trend towards an in-
creased frequency of the variant genotype 823 C/T 
(heterozygotes) was observed in pulmonary TB pa-
tients than control and spinal TB patients (odds ratio 
(OR) : 1.6; confidence interval (CI): 0.74–3.4). A 
trend towards an increased frequency of the variant 
genotype TGTG del/del of 3'-UTR was observed in 
control subjects than pulmonary and spinal TB pa-
tients (OR : 0.48; CI: 0.10–1.78; OR: 0.42; CI: 0.04–
2.12, respectively). The above trends were not sig-
nificant. The study suggests that NRAMP1 gene may 
not be associated with the susceptibility to pulmo-
nary and spinal TB in the Indian population. Major 
Histocompatibility Complex (MHC) and other non-
MHC gene polymorphic variants may be associated. 
 
IN inbred mouse strains, infection with the nonpatho-
genic M. bovis BCG has been shown to be controlled by 
a single dominant gene present on chromosome 1, des-
ignated as Bcg, which is present in two allelic forms: 
Bcgr (resistant, dominant), Bcgs (susceptible, reces-
sive)1. The Bcg gene is identical to two other genes, 
known as Ity2 and Lsh3, which control natural resistance 
to infection with other unrelated intracellular parasites, 
including Salmonella typhimurium and Leishmania 
donovani4. 
 A candidate gene for Bcg was isolated by positional 
cloning and was shown to be expressed in the macro-
phage. This gene was designated as Nramp1, for natural 
resistance-associated macrophage protein 1 (ref. 5). The 
Nramp1 protein is an integral membrane protein which 
localizes to the phagosome membrane6 and may act as a 
divalent cation transporter. Sequence analysis of the 
Nramp1 gene in Bcgr and Bcgs inbred strains revealed 
that susceptibility to infection was associated with a 
nonconservative glycine to aspartic acid substitution at 
position 169 (ref. 7). 
 The human homologue of the Nramp1 gene, desig-
nated NRAMP1, has been suggested to be a strong can-
didate gene for human TB susceptibility. NRAMP1 has 
been cloned and mapped to human chromosome 2q35 
(refs 8 and 9) and codes for a polytopic transmembrane 
protein which shares a homology of 88% with mouse 
Nramp1. 
 Several polymorphisms have been described in the 
NRAMP1 gene, and it has been suggested that they may 
influence the function of the gene10–12. Few studies on 
NRAMP1 gene polymorphism have been carried out in 
mycobacterial diseases such as leprosy13–15 and TB16,17. 
Recently, it has been reported that genetic variants of 
the NRAMP1 gene are associated with a significantly 
increased risk of pulmonary TB in West African (Gam-
bia) and Korean populations16,17. However, our earlier 
study on the NRAMP1 CA repeat microsatellite poly-
morphism at 199 and 201, revealed no association with 
the susceptibility or resistance to pulmonary TB in the 
Indian population (Selvaraj et al., unpublished). Since, 
very few studies have been carried out in TB and no 
such study was carried out in the Indian population, the 
present study was carried out to find out whether other 
NRAMP1 gene variants such as 823 C/T, TGTG pres-
ence or deletion in 3′-UTR (3′ untranslated region), and 
D543N G/A are associated with the susceptibility or 
resistance to pulmonary and spinal TB in south Indian 
population. 
 Subjects included in this study were 100 pulmonary 
TB patients, 57 spinal TB patients and 112 control sub-
jects. Among the pulmonary TB patients, 77 were males 
and 23 females, aged 40.5 ± 1.3 (mean ± SE) and 
38.9 ± 2.5 years, respectively. Of the spinal TB patients, 
26 were males and 31 females, aged 39.5 ± 3.3 years 
and 45.8 ± 2.5 years, respectively. Among the control 
subjects studied, 53 were males and 59 were females. 
The mean age with SE was 40.5 ± 1.4 year for males 
and 36.8 ± 1.1 year for females. 
 Patients attending the Tuberculosis Research Centre 
(TRC), Chennai with respiratory symptoms and radio-
graphic abnormalities suggestive of pulmonary TB were 
studied. These patients were sputum-positive for M. 
tuberculosis by smear and culture, and are known as 
active pulmonary TB patients. They were given super-
vised short course anti TB treatment for 6 to 8 months 
duration and cured. They had been followed up for 5 
years after treatment. At the time of blood sample col-
lection, all the cured patients were in the quiescent 
stage. 
 Patients with clinically and radiologically active form 
of spinal TB involving any vertebral body from the first 
thoracic to the first sacral, inclusive, were studied. The 
pre-treatment investigations were radiograph of the 
chest, examination by culture of two specimens of pus 
from any abscess or sinus, with radiographic evidence 
of pulmonary TB. All these patients had received a su-
RESEARCH COMMUNICATIONS 
 
CURRENT SCIENCE, VOL. 82, NO. 4, 25 FEBRUARY 2002 452 
pervised short course chemotherapy of 6 to 9 months 
duration and followed up for a period of 5 years after 
treatment. At the time of blood sample collection, all 
these cured patients were in a quiescent stage of the 
disease18. 
 Control subjects consisted of spouses of the patients 
(family contacts) (n = 65) and staff of TRC (n = 47). 
The patient contacts (spouses) were living together with 
the patients before, during and after treatment and the 
staff of TRC, working for more than 3 years. The family 
contacts and the other control subjects were clinically 
normal at the time of blood sample collection. The pa-
tients and the contacts were not consanguineous to each 
other. The study subjects were randomly selected and 
belonged to the same ethnic origin (Indo-Dravidian de-
scent). They were Tamil-speaking, south Indian popula-
tion living in and around Chennai. 
 DNA was extracted from the peripheral blood white 
cells using a salting-out procedure19. Genotyping of 823 
C/T, TGTG deletion, D543N polymorphisms of 
NRAMP1 gene was carried out. 
 823 C/T polymorphism was defined by a point muta-
tion at codon 249 in exon 8 (GGC to GGT) encoding 
glycine. The following primers were used to amplify 
this region10. 5'-CTT GTC CTG ACC AGG CTC CT-3'; 
5'-CAT GGC TCC GAC TGA GTG AG-3'. 
 The PCR cycle conditions were as follows: after an 
initial denaturation step at 94°C for 4 min, 35 cycles of 
denaturation at 94°C for 30 s, annealing at 63°C for 30 s 
and extension at 72°C for 30 s followed by 2 min exten-
sion at 72°C using 20 mM Tris, pH 8.4; 50 mM KCl; 
1 mM MgCl2; 0.4 mM dNTPs (Gibco BRL, Grand Is-
land, NY, USA); 0.1 µM of each primer; 100 ng of ge-
nomic DNA, and 1 unit of Taq polymerase (Genei, 
Bangalore) in a 25 µl reaction mixture. The PCR was 
carried out in a programmable thermal cycler (M. J. 
Research Inc., Waltham, MA, USA). 
 The amplified 234-base pair (bp) PCR product was 
checked electrophoretically in a 1.5% agarose gel. Five 
µl of the PCR product was restriction digested with 5 
units of NarI enzyme (Gibco BRL, Grand Island, NY, 
USA) at 37°C for 3 h using the manufacturer’s buffer in 
a total volume of 20 µl. The fragments were checked in 
a 2% agarose gel run at 80 V for 35 min. The presence 
of the fragments 135 bp and 99 bp represents homozy-
gotes of the common allele, 234 bp, 135 bp and 99 bp 
represent the presence of common and infrequent alleles 
(heterozygote carriers). Presence of only 234 bp frag-
ment represents the homozygotes of the infrequent al-
lele10. 
 TGTG presence or deletion polymorphism in the 3'-
UTR was defined by a deletion of 4 bases in the 3′-UTR 
(55 nucleotides to the last codon in exon 15), also rep-
resented as 1729 + 55 del 4. The following primers 
(Gibco BRL, Grand Island, NY, USA) were used to am-
plify the 3′-UTR region, as described earlier15,16: 5′-
GCA TCT CCC CAA TTC ATG GT-3′; 5′-AAC TGT 
CCC ACT CTA TCC TG-3′. 
 The PCR cycle conditions were as follows: after an 
initial denaturation step at 94°C for 4 min followed by 5 
cycles of denaturation at 94°C for 15 s, annealing at 
58°C for 30 s and extension at 72°C for 30 s, proceeded 
by 30 cycles of denaturation at 94°C for 15 s, annealing 
at 53°C for 30 s and extension at 72°C for 30 s followed 
by 2 min extension at 72°C, using 10 mM Tris, pH 8.3; 
25 mM KCl; 1 mM MgCl2; 0.4 mM dNTPs (Gibco 
BRL, Grand Island, NY, USA); 0.1 µM of each primer 
(Gibco BRL, Grand Island, NY, USA); 100 ng of ge-
nomic DNA, and 1 unit of Taq polymerase (Genei, 
Bangalore) in a 25 µl reaction mix15. The PCR was car-
ried out in a programmable thermal cycler (M. J. Re-
search Waltham, MA, USA). The amplified PCR 
product (240 bp) was dot-blotted and detected using the 
following biotinylated sequence-specific oligonucleo-
tide probes (SSOP) (Gibco BRL, Grand Island, NY, 
USA). Presence of TGTG: 5′-CTG GAT GTG GAG 
GGG G-3′; deletion of TGTG: 5'-TGC TGG AGA GGG 
GGC-3′. 
 The PCR product (10 µl) was denatured by adding 
90 µl of freshly prepared denaturing solution (9.9 ml of 
Tris EDTA [ethylene diamine tetraacetic acid], pH 8.0; 
0.66 ml of 0.5 M EDTA, pH 8.0 and 0.88 ml of 6 M 
NaOH). The mixture was placed on ice for ten minutes 
for the denaturation process and 100 µl of 2M ammo-
nium acetate was added to the denaturing mixture to 
stop the reaction. The DNA was dot-blotted on Nytran 
membrane (Boehringer Mannheim GmbH, Germany) 
using a dot-blot apparatus (Gibco BRL, Grand Island, 
NY, USA). The membrane was UV cross-linked in a 
UV cross-linker (Bio-Rad, Hercules, CA, USA) at 250 
mJ and stored at –20°C until use. 
 The membrane was blocked with 10 ml blocking so-
lution {4 × SSPE, 1% casein hydrolysate (SRL, Mum-
bai) and 0.1% laurylsarcosine (SRL, Mumbai)} in a 
hybridization oven (Hybaid Ltd, UK) at room tempera-
ture for 30 min. Prehybridization was done with 15 ml 
of hybridization solution [3M TMAC (tetramethylam-
monium chloride; SRL, Mumbai); 50 mM Tris, pH 8.0, 
0.1% SDS (sodium dodecyl sulphate), and 2 mM 
EDTA] for 45 min at 53°C, in the hybridization oven. 
 Biotinylated SSOPs (10 pmol/ml) were added to the 
hybridization solution and hybridization was carried out 
overnight at 53°C. Membranes were then washed with 
25 ml of wash buffer (2X SSPE, 0.1% SDS) at room 
temperature and stringency wash step was carried out 
with 15 ml of TMAC for 15 min at 58°C for both 
probes. 
 After stringency wash, the membrane was washed in 
wash buffer. The washed membrane was blocked with 
20 ml of blocking solution (NaCl 125 mM, NaH2PO4 
17 mM, Na2HPO4 8 mM, SDS 173 mM) for 15 min at 
room temperature. The signal was detected using Pho-
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totope – Star Detection Kit (New England Biolabs Inc, 
Beverly, USA). Blocking solution (50–60 µl/cm2) con-
taining streptavidin (1 µg/ml) was added to the mem-
brane and incubated at room temperature for twenty 
minutes. The membrane was washed two times in 20 ml 
wash solution-I for 15 min each (1 : 10 diluted blocking 
solution, 0.5 ml/cm2) at room temperature. This was 
followed by biotinylated alkaline phosphatase 
(0.5 µg/ml in blocking solution, 50 µl solution per cm2 
membrane) incubation for 20 min at room temperature. 
The membrane was washed twice in 20 ml of wash 
solution-II [Tris-HCl 10 mM, pH 9.5; NaCl 10 mM and 
MgCl2 1 mM], drained and treated with Lumigen-PPD 
substrate for 5–7 min. The membrane was kept wet in 
Saran wrap or cling film and the chemiluminescent signal 
was detected on X-ray film, after exposing the membrane 
for 5–10 min and 30 min, respectively. The membrane 
was stored until further use at – 20°C in a wet condition 
to ensure that it did not dry, as drying of the membrane 
leads to irreversible probe and DNA hybridization. 
 The membranes were washed with 20 ml of stripping 
buffer-1 (20 mM EDTA and 2X SSC) for 30 min at 
65°C. The second wash was done with 20 ml of strip-
ping buffer-II (2X SSC and 0.1% SDS) for 15 min at 
room temperature. The membranes were then washed in 
stripping buffer-III (0.2 M NaOH, 0.1% SDS) at 37°C 
for 30 min. The stripped membranes were reprobed with 
the other probe. 
 D543N polymorphism was defined by a mutation in 
codon 543 involving a change of GAC (Asp) to AAC 
(Asn). Primers and PCR conditions were the same as 
those of 3′-UTR10,15,16. Five µl of the PCR product (240 
or 244 bp) was subjected to restriction digestion with 
AvaII enzyme (5 units) (Gibco BRL, Grand Island, NY, 
USA) in the presence of manufacturer’s buffer in a total 
reaction mix of 20 µl for 3 h at 37°C. The common al-
lele (G) was designated by the presence of 126, 79 and 
39 bp bands and the infrequent allele was designated by 
the presence of 201 and 39 bp products10. 
 The frequencies of the genotypes in the patient 
groups and controls were analysed using χ2 with Yates 
correction (χy2). These analyses were carried out em-
ploying the Statcalc program (Epi Info, Version – 5; 
USD; Stone Mountain, GA, USA). 
 The NRAMP1 – 823 C/T polymorphism did not show 
any deviation in the genotype frequencies between the 
control and the patients. However, a trend towards an 
increased genotype frequency of the heterozygote com-
bination (C/T) of 823 polymorphism was seen in pul-
monary TB patients than control subjects and spinal TB 
patients. However, this was not significant (P > 0.05; 
OR: 1.6; CI: 0.74–3.4, Table 1). 
 No difference in the variant genotype frequencies of 
3′-UTR TGTG positive/positive (TGTG+/+) was ob-
served among control, pulmonary and spinal TB pa-
tients. However, a trend towards an increased TGTG 
positive/deletion (TGTG+/del) genotype was observed 
in pulmonary TB patients, but not significant (P > 0.05; 
OR: 1.4; CI: 0.6–3.4). A trend towards an increased 
genotype frequency of TGTG deletion/deletion (TGTG 
del/del) was observed in control subjects than pulmo-
nary and spinal TB patients. However, this was not sig-
nificant (P > 0.05; CI: 0.10–1.78; P > 0.05; CI: 0.04–
2.12, respectively). The D543N polymorphism which is 
in strong linkage disequilibrium with 3′-UTR, also 
showed no difference among the control and the patient 
groups studied (Table 1). 
 The variant genotype frequencies of NRAMP1 gene 
polymorphisms – 823 C/T (exon 8), 3′-UTR TGTG de-
letion and D543N (exon 15) did not differ among the 
control subjects and the pulmonary and spinal TB pa-
tients. Similarly, our earlier study on 5′- (CA)n microsa-
tellite polymorphism at exon 1, also revealed no 
difference in the genotype frequencies between the con-
trols and pulmonary TB patients (Selvaraj et al., unpub-
lished). This suggests that NRAMP1 gene may not be 
associated with the susceptibility to pulmonary and spi-
nal TB in India. In a study carried out in Indian leprosy 
patients, no significant association was observed be-
tween the leprosy types and the four NRAMP1 gene 
polymorphisms studied15. 
 
 
Table 1. Genotype frequencies of NRAMP1 – 823 C/T, 3′-UTR 
TGTG+/del, and D543N G/A gene polymorphisms in control, pul- 
  monary and spinal TB patients 
 Percentage genotype frequency 
Variant 
NRAMP1  Control  Pulmonary TB Spinal TB 
genotype  (n = 112) (n = 100) (n = 57) 
 
823 CT 
C/C 82.1 78.0 86.0 
 (92) (78) (49) 
C/T 15.2* 22.0* 14.0 
  (17) (22) (8) 
T/T 2.7 0.0 0.0 
  (3) (0) (0) 
3′-UTR  
 
TGTG +/+ 81.3 82.0  86.0 
  (91) (82) (49) 
TGTG +/del 10.7**  14.0**  10.5 
  (12) (14) (6) 
TGTG del/del 8.0 4.0  3.5 
  (9) (4) (2) 
D543N   
G/G 83.0 82.0 80.7 
 (93) (82) (46) 
G/A 17.0  17.0 19.3 
  (19) (17) (11) 
A/A 0.0 1.0 0.0 
  (0) (1) (0) 
n = subjects studied; Numbers in parenthesis represent the subjects 
positive for various genotypes. 
*OR = 1.4; **OR = 1.6. 
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 The lack of association of NRAMP1 polymorphisms 
in this population does not rule out an association with 
the gene in other ethnically different populations. In a 
case control study carried out in West African popula-
tion, it has been shown that NRAMP1 gene polymor-
phisms are associated with the susceptibility to 
pulmonary TB16. It has been suggested that 3′-UTR 
variant allele associated with susceptibility to TB is 
uncommon in Europeans10, but was present in about a 
quarter of this West African population16. Association 
of 3′-UTR polymorphism with the susceptibility to 
pulmonary TB has also been reported in Korean popula-
tion17. 
 Our earlier study20 on HLA revealed the association 
of HLA-DR2 with the susceptibility to pulmonary TB, 
whereas no such association was observed in West Af-
rican population. Further, our study21 on mannose-
binding protein (MBP) gene polymorphism revealed 
that functional mutant homozygotes are associated with 
the susceptibility to pulmonary TB. Whereas in Gam-
bian pulmonary TB patients and control, neither homo-
zygotes nor heterozygotes of mannose-binding lectin 
(MBL) gene variants 54 and 57 (functional mutant ho-
mozygotes) were at increased risk of pulmonary TB22. 
Moreover, our study on vitamin-D receptor gene poly-
morphism23 revealed the association of tt genotype with 
the susceptibility to pulmonary TB in female patients, 
and TT genotype with resistance to pulmonary TB in 
female contacts in India. In the Gambian pulmonary TB 
patients, the tt genotype of VDR gene was found less 
frequently in cases of pulmonary TB, suggesting that 
this genotype may be associated with resistance to pul-
monary TB24. Interestingly, NRAMP1 gene polymorphic 
variants are associated with the susceptibility to TB in 
the Gambian population (West Africa)16, whereas our 
present study in Indian TB patients revealed no associa-
tion of NRAMP1 gene variants with the susceptibility or 
resistance to TB. This type of association may be due to 
gene–environment interaction. 
 The present study suggests that NRAMP1 gene poly-
morphic variants may not be associated with the suscep-
tibility to TB similar to leprosy (another mycobacterial 
disease). In the Indian population, NRAMP1 gene vari-
ants may not be the dominant alleles, probably other 
Major Histocompatibility Complex (MHC) and non-
MHC genes may be associated with the susceptibility to 
mycobacterial diseases such as TB and leprosy. 
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